Free Trial
NASDAQ:DWTX

Dogwood Therapeutics Q1 2025 Earnings Report

Dogwood Therapeutics logo
$4.85 +0.01 (+0.21%)
Closing price 08/1/2025 03:54 PM Eastern
Extended Trading
$4.78 -0.07 (-1.55%)
As of 08/1/2025 06:11 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Dogwood Therapeutics EPS Results

Actual EPS
-$4.21
Consensus EPS
-$0.77
Beat/Miss
Missed by -$3.44
One Year Ago EPS
N/A

Dogwood Therapeutics Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Dogwood Therapeutics Announcement Details

Quarter
Q1 2025
Time
Before Market Opens
Conference Call Date
Thursday, May 8, 2025
Conference Call Time
9:00AM ET

Upcoming Earnings

Dogwood Therapeutics' Q2 2025 earnings is scheduled for Wednesday, August 6, 2025

Dogwood Therapeutics Earnings Headlines

Dogwood Therapeutics Approves CFO Salary Increase
Here’s How to Claim Your Stake in Elon’s Private Company, xAI
Even though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks like you… To partner with Elon on what he believes will be the biggest AI project of the century… Starting with as little as $500.
DWTX Dogwood Therapeutics, Inc.
See More Dogwood Therapeutics Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Dogwood Therapeutics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Dogwood Therapeutics and other key companies, straight to your email.

About Dogwood Therapeutics

Dogwood Therapeutics (NASDAQ:DWTX). is a development-stage biotechnology company, which engages in developing therapeutics for pain and fatigue illness. Its product includes Halneuron. It focuses on antiviral therapies IMC-1 and IMC-2 to treat diseases associated with a viral triggered abnormal immune response such as Long-COVID and fibromyalgia. The company was founded on February 28, 2012 is headquartered in Alpharetta, GA.

View Dogwood Therapeutics Profile

More Earnings Resources from MarketBeat